206 related articles for article (PubMed ID: 21437910)
1. Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention.
Alukda D; Sturgis T; Youan BC
J Pharm Sci; 2011 Aug; 100(8):3345-3356. PubMed ID: 21437910
[TBL] [Abstract][Full Text] [Related]
2. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
Zhang T; Sturgis TF; Youan BB
Eur J Pharm Biopharm; 2011 Nov; 79(3):526-36. PubMed ID: 21736940
[TBL] [Abstract][Full Text] [Related]
3. Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.
Meng J; Sturgis TF; Youan BB
Eur J Pharm Sci; 2011 Sep; 44(1-2):57-67. PubMed ID: 21704704
[TBL] [Abstract][Full Text] [Related]
4. Spray drying tenofovir loaded mucoadhesive and pH-sensitive microspheres intended for HIV prevention.
Zhang T; Zhang C; Agrahari V; Murowchick JB; Oyler NA; Youan BB
Antiviral Res; 2013 Mar; 97(3):334-46. PubMed ID: 23274788
[TBL] [Abstract][Full Text] [Related]
5. Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis.
Chaowanachan T; Krogstad E; Ball C; Woodrow KA
PLoS One; 2013; 8(4):e61416. PubMed ID: 23630586
[TBL] [Abstract][Full Text] [Related]
6. Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.
Meng J; Zhang T; Agrahari V; Ezoulin MJ; Youan BB
Nanomedicine (Lond); 2014 Aug; 9(11):1595-612. PubMed ID: 24405490
[TBL] [Abstract][Full Text] [Related]
7. Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV prevention.
Akil A; Agashe H; Dezzutti CS; Moncla BJ; Hillier SL; Devlin B; Shi Y; Uranker K; Rohan LC
Pharm Res; 2015 Feb; 32(2):458-68. PubMed ID: 25079391
[TBL] [Abstract][Full Text] [Related]
8. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
Akil A; Devlin B; Cost M; Rohan LC
Mol Pharm; 2014 May; 11(5):1533-41. PubMed ID: 24693866
[TBL] [Abstract][Full Text] [Related]
9. Layer-by-Layer Engineered Microbicide Drug Delivery System Targeting HIV-1 gp120: Physicochemical and Biological Properties.
Coulibaly FS; Ezoulin MJM; Purohit SS; Ayon NJ; Oyler NA; Youan BC
Mol Pharm; 2017 Oct; 14(10):3512-3527. PubMed ID: 28830144
[TBL] [Abstract][Full Text] [Related]
10. Vaginal deployment and tenofovir delivery by microbicide gels.
Gao Y; Yuan A; Chuchuen O; Ham A; Yang KH; Katz DF
Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971
[TBL] [Abstract][Full Text] [Related]
11. Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery.
Krogstad EA; Woodrow KA
Int J Pharm; 2014 Nov; 475(1-2):282-91. PubMed ID: 25169075
[TBL] [Abstract][Full Text] [Related]
12. Physico-chemistry and Cytotoxicity of Tenofovir-Loaded Acid Phosphatase-Responsive Chitosan Nanoparticles.
Ngo AN; Murowchick J; Gounev AD; Gounev TK; Youan BC
AAPS PharmSciTech; 2023 Jun; 24(6):143. PubMed ID: 37353718
[TBL] [Abstract][Full Text] [Related]
13. Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections.
Timur SS; Şahin A; Aytekin E; Öztürk N; Polat KH; Tezel N; Gürsoy RN; Çalış S
Pharm Dev Technol; 2018 Mar; 23(3):301-310. PubMed ID: 28503983
[TBL] [Abstract][Full Text] [Related]
14. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies.
Dodiya S; Chavhan S; Korde A; Sawant KK
Drug Dev Ind Pharm; 2013 May; 39(5):733-43. PubMed ID: 22690834
[TBL] [Abstract][Full Text] [Related]
16. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system.
Machado A; Cunha-Reis C; Araújo F; Nunes R; Seabra V; Ferreira D; das Neves J; Sarmento B
Acta Biomater; 2016 Oct; 44():332-40. PubMed ID: 27544812
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of polycaprolactone matrices for vaginal delivery of the antiviral, tenofovir, in preventing heterosexual transmission of HIV.
Dang NT; Sivakumaran H; Harrich D; Coombes AG
J Pharm Sci; 2013 Oct; 102(10):3725-35. PubMed ID: 23904196
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of in-vitro cytotoxicity and cellular uptake efficiency of zidovudine-loaded solid lipid nanoparticles modified with Aloe Vera in glioma cells.
K S J; Sharma CP; Kalarikkal N; Sandeep K; Thomas S; Pothen LA
Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():40-50. PubMed ID: 27207037
[TBL] [Abstract][Full Text] [Related]
19. Chemico-physical investigation of tenofovir loaded polymeric nanoparticles.
Belletti D; Tosi G; Forni F; Gamberini MC; Baraldi C; Vandelli MA; Ruozi B
Int J Pharm; 2012 Oct; 436(1-2):753-63. PubMed ID: 22884838
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.
Dang NT; Sivakumaran H; Harrich D; Shaw PN; Davis-Poynter N; Coombes AG
Eur J Pharm Biopharm; 2014 Oct; 88(2):406-14. PubMed ID: 24887313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
